Exosome-based therapies for mucosal delivery.

Int J Pharm

Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, SE1 9NH London, United Kingdom. Electronic address:

Published: October 2021

Exosomes are membrane-bound extracellular nanovesicles secreted by most cells and found in multiple sources, including bodily fluids, plants, fruit, and bovine milk. They play an important role as mediators of intercellular communication, having a distinct ability to carry small molecules, proteins, and nucleic acids to recipient cells over large distances. Moreover, competency in crossing usually poorly permeable biological barriers has led to their promising use in diagnostics and in therapeutics, either as therapeutic entities on their own or as drug delivery vehicles, with superior stability, biocompatibility, circulation time and target specificity in comparison to conventional drug delivery systems. The aim of this review is to summarise and critically discuss the current literature on the use of exosomes in a therapeutic setting, with a particular focus on their use as drug delivery vehicles for mucosal drug delivery.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpharm.2021.121087DOI Listing

Publication Analysis

Top Keywords

drug delivery
16
delivery vehicles
8
delivery
5
exosome-based therapies
4
therapies mucosal
4
mucosal delivery
4
delivery exosomes
4
exosomes membrane-bound
4
membrane-bound extracellular
4
extracellular nanovesicles
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!